An improved method for the measurement of 1,25-(OH)2D3 in human plasma.

Here we report a highly sensitive and convenient ligand binding assay for the determination of 1,25(OH)2D3 in small volumes of human plasma. This method involves: (1) extraction of vitamin D3 and its metabolites using methanol-methylene chloride with separation of phases by centrifugation; (2) gel chromatography and high pressure liquid chromatography for the quantitative isolation of 1,25-(OH)2D3; and (3) a sensitive ligand binding assay for 1,25-(OH)2D3 employing cytosol receptor from the intestinal mucosa of rachitic chicks. Using modified rachitogenic chick diets allows early (less than 4 wks) harvesting of active receptor for 1,25-(OH)2D3 in high yield. The method includes a rapid and effective procedure for stable and long-term storage of the active cytosol receptor. A convenient dextran-charcoal means is used for the separation of receptor bound from free 1,25-(OH)2D3 resulting in the achievement of a lower (less than 5%) background (i.e., nonspecific binding) than reported for other 1,25-(OH)2D3 assays. Analysis of this receptor shows it to be a saturable, single class of binding sites with a dissociation constant (Kd) of approximately 3.7 x 10-11. The final recovery of 1,25-(OH)2D3 following extraction and chromatography is 80 +/- 3% and triplicate determinations can be made on a 3 ml plasma sample. The ligand binding assay routinely detects less than or equal to 5pg of 1,25-(OH)2D3 per assay tube and the inter- and intraassay variation, based on repeated determinations of 1,25-(OH)2D3 in pooled normal human plasma, is less than 5%. Preliminary studies indicate that our methodology will permit measurement of plasma 1,25-(OH)2D3 levels in all normal subjects and in pathophysiologic states where 1,25-(OH)2D3 levels may be below or above normal values. 1,25-(OH)2D3 values (pg/ml +/- SEM) in human plasma obtained from both normals and patients with various untreated calcium homeostatic disorders were: normals = 33.5 +/- 1.8; end-stage chronic renal failure = 5.1 +/- 1.2; primary hypoparathyroidism = 18.3 +/- 2.8; primary hyperparathyroidism = 61.4 +/- 7.1; and hyperthyroidism with associated hypercalcemia = 42.1 +/- 8.4.

[1]  M. Scrutton.  Vitamin D: Biochemical, Chemical and Clinical Aspects related to Calcium Metabolism , 1979 .

[2]  H. DeLuca,et al.  A bioassay capable of measuring 1 picogram of 1,25-dihydroxyvitamin D3. , 1978, The Journal of clinical endocrinology and metabolism.

[3]  M. Haussler,et al.  Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). , 1977, The New England journal of medicine.

[4]  T. Spelsberg,et al.  Isolation and quantitation of endogenous vitamin D and its physiologically important metabolites in human plasma by high pressure liquid chromatography. , 1977, Journal of steroid biochemistry.

[5]  J. Lemann,et al.  The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. , 1977, The Journal of clinical endocrinology and metabolism.

[6]  V. Moudgil,et al.  Binding of ATP to Progesterone Receptors: Properties and Functional Significance of This Interaction * , 1977, Annals of the New York Academy of Sciences.

[7]  J. Haddad,et al.  Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol. , 1976, The Journal of clinical endocrinology and metabolism.

[8]  H. DeLuca,et al.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.

[9]  M. Haussler,et al.  Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. , 1976, The Journal of clinical investigation.

[10]  I. Macintyre,et al.  REGULATION OF VITAMIN D: AN EVOLUTIONARY VIEW , 1976, Clinical endocrinology.

[11]  M. Haussler,et al.  THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS , 1976, Clinical endocrinology.

[12]  H. DeLuca,et al.  High-pressure liquid chromatography: separation of the metabolites of vitamins D2 and D3 on small-particle silica columns. , 1975, Journal of lipid research.

[13]  K. Schaefer,et al.  Vitamin D and problems related to uremic bone disease. , 1975 .

[14]  H. Rasmussen,et al.  A comparison of the metabolism of 25-hydroxyvitamin D3 by chick renal tubules, homogenates and mitochondria. , 1974, Biochimica et Biophysica Acta.

[15]  M. Preece,et al.  A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. , 1974, Clinica chimica acta; international journal of clinical chemistry.

[16]  B. Tulloch,et al.  Effects of nucleotides, hormones, ions, and 1,25-dihydroxycholecalciferon on 1,25-dihydroxycholecalciferol production in isolated chick renal tubules. , 1974, Clinical science and molecular medicine.

[17]  M. Haussler,et al.  Radioreceptor Assay for 1α,25-Dihydroxyvitamin D3 , 1974, Science.

[18]  A. Norman,et al.  The role of the kidney and vitamin D metabolism in health and disease. , 1974, Clinical orthopaedics and related research.

[19]  D. Moss,et al.  Regulation of vitamin D metabolism: factors influencing the rate of formation of 1,25-dihydroxycholecalciferol by kidney homogenates. , 1973, The Biochemical journal.

[20]  M. Haussler.  Characterization of the metabolites of vitamin D 3 in the chick. , 1972, Steroids.

[21]  H. DeLuca,et al.  The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. , 1972, Endocrinology.

[22]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture , 1972, Science.

[23]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[24]  H. DeLuca,et al.  1,25-dihydroxycholecalciferol: the metabolite of vitamin D responsible for increased intestinal calcium transport. , 1971, Archives of biochemistry and biophysics.

[25]  H. DeLuca,et al.  Competitive binding assay for vitamin D and 25-OH vitamin D. , 1971, The Journal of clinical endocrinology and metabolism.

[26]  H. Nowicki,et al.  Studies on calciferol metabolism. I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates. , 1971, Biochemical and biophysical research communications.

[27]  D. Fraser,et al.  Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.

[28]  H. DeLuca,et al.  "Activation" of vitamin D by the liver. , 1969, The Journal of clinical investigation.

[29]  H. DeLuca,et al.  In vitro production of 25-hydroxycholecalciferol. , 1969, Biochemical and biophysical research communications.

[30]  H. DeLuca,et al.  Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. , 1967, The Journal of clinical investigation.

[31]  A. Root,et al.  Recent advances in calcium metabolism. , 1966, R.I. medical journal.

[32]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .